Navigating through Multiple Sclerosis Disease Landscape through DLI’s Clinical Trial Management, Product Development Services, Drug Launch Strategies, and Market Access | Disease Landscape Insights

LONDON, Oct. 10, 2023 /PRNewswire/ — Multiple Sclerosis Disease, a chronic autoimmune disease affects a large proportion of the world population. According to an epidemiology study conducted by the WHO, more than 1.8 million individuals are affected with MS globally. This growing disease…